EndoTODAY | EndoATLAS | OPD

Parasite | Eso | Sto | Cancer | ESD

Boxim | DEX | Sono | Schedule

Home | Recent | Blog | Links


[À§¾Ï 75]

Previous | Next

001 | 101 | 201 | 301 | 401 | 501 | 601 | 701 | 801 | 901 | 1000


Nodal lymphoma ȯÀÚÀÔ´Ï´Ù.




¾Æ·¡·Î




¾Æ·¡·Î




¾Æ·¡·Î




¾Æ·¡·Î




¾Æ·¡·Î





Mantle cell lymphoma(MCL, ¿ÜÅõ¸·¼¼Æ÷¸²ÇÁÁ¾)´Â non-Hodgkin lymphomaÀÇ 6%Á¤µµ¸¦ Â÷ÁöÇÏ´Â B cell lymphoma·Î t(11:14)¿¡ ÀÇÇÑ cyclin D1 overexpressionÀ» Ư¡À¸·Î ÇÏ´Â ÁúȯÀÔ´Ï´Ù. °æºÎ ¸²ÇÁÀýÀÌ Ä¿Á®¼­ º´¿øÀ» ã´Â °æ¿ì°¡ ¸¹½À´Ï´Ù.

Nodal MCLÀÇ À§Àå°ü ħ¹ü¿¡ ´ëÇؼ­´Â °ú°Å¿¡´Â 1/3 Á¤µµ·Î »ý°¢ÇÏ¿´À¸³ª Á¡Â÷ ±× ¼öÄ¡°¡ ³ô¾ÆÁö´õ´Ï ÃÖ±Ù¿¡´Â 70-80% ÀÌ»óÀ¸·Î ÃßÁ¤µÇ°í ÀÖ½À´Ï´Ù. ³»½Ã°æ¿¡¼­ ÀÌ»ó¼Ò°ßÀ» º¸ÀÌ´Â ºÎÀ§ »Ó¸¸ ¾Æ´Ï¶ó Á¤»óÀ¸·Î º¸ÀÌ´Â À§ÀåÁ¡¸·¿¡¼­ Á¶Á÷°Ë»ç¸¦ ÇØ º¸¸é MCLÀÇ Ä§À±ÀÌ Áõ¸íµÈ´Ù°í ÇÕ´Ï´Ù. »ç½Ç °ÅÀÇ ´ëºÎºÐÀÇ È¯ÀÚ°¡ À§Àå°ü±îÁö ħ¹üµÇ¾î ÀÖ´Ù°í »ý°¢ÇÏ´Â °ÍÀÌ ÁÁ½À´Ï´Ù. Áï MCL´Â óÀ½ºÎÅÍ systemic diseaseÀÎ ¼ÀÀÌÁö¿ä. Nodal MCLÀÇ À§Àå°ü ħ¹ü¿¡ ´ëÇÑ ¹®Çå µÎ °³¸¦ ¼Ò°³ÇÕ´Ï´Ù.

[Romaguera. Cancer 2003;97(3):586-91] Only 26% of patients presented with GI symptoms at the time of diagnosis. MCL was present histologically in the lower GI tract of 53 of 60 patient (88%) and in the upper GI tract of 28 of 58 patients (43%). Microscopic evidence of MCL was found in 84% of patients with normal visual (macroscopic) findings by lower endoscopy and in 45% of patients with macroscopically normal findings by upper endoscopy.

[Salar A. Am J Surg Pathol 2006;30(10):1274-80] Abnormal mucosa was identified in 38% of cases by upper endoscopy (mainly mild nonspecific gastritis) and in 54% of cases by lower endoscopy (mostly micropolyps). Histologically, infiltration by MCL was demonstrated in the stomach in 77% of cases and in the colon in 77% of cases. As a whole, 92% of patients showed upper or lower GI tract infiltration by MCL.

2014. 6. 21. ÀÌÁØÇà